Dr. Maxine Caws

Dr Max Caws is a Senior Tuberculosis Researcher at Liverpool School of Tropical Medicine, UK, working with Birat Nepal Medical Trust (BNMT Nepal) in Kathmandu, Nepal.

She is the Principal Investigator for many research projects including the international IMPACT TB consortium (www.impacttbproject.org) to scale-up and generate evidence to inform policy decisions on active case finding within the national TB programmes of Vietnam and Nepal, and the Epidemic Intelligence consortium project on COVID-19 sequencing (www.epiintelnepal.org).

She has worked on tuberculosis for over twenty years and her research interests span the full spectrum of the complex challenges in TB elimination, from phylogenetic evolution and virulence of the bacilli to novel diagnostics, drug resistance, clinical treatment trials and socioecomonic aspects. She was previously Head of the Tuberculosis Research Group at Oxford University Clinical Research Unit (OUCRU-Viet Nam), Ho Chi Minh City, Viet Nam for eleven years (2003-2014) and a University Research Lecturer at Oxford University, UK.

She has published over 100 articles in international peer-reviewed journals and book chapters, including high impact articles in Nature Genetics, Science Advances and Lancet Infectious Diseases and sits on international grant review panels, national advisory boards and clinical trial data safety monitoring boards (DSMB). She is supported by a portfolio of funding including the Wellcome Trust, European Union, UK Medical Research Council, Australian National Health Medical Research Council, Americares, Farrar Foundation and TB modelling Analysis Consortium.

She holds a PhD from King’s College London, an MSc in epidemiology from London School of Hygiene and Tropical Medicine and a BSc degree in Biochemistry from the University of St Andrews, UK.